Targeted therapy.

Wilmington, Delaware, United States, July 10, 2023 (GLOBE NEWSWIRE) -- The global prostate cancer therapeutics market is projected to expand at a CAGR of 6.9% from 2022 to 2031 to reach…

The research was led by Dr. Darren Wong and guided by Assoc. Prof. Low Boon Chuan revealed how BPGAP1 synchronizes two critical proteins involved in cell migration, GTPases Rac1 and…

<!-- Name:DistributionId Value:8791236 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…

<!-- Name:DistributionId Value:8784520 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…

Selbyville, Delaware, Aug. 16, 2022 (GLOBE NEWSWIRE) -- The pet cancer therapeutics market value is anticipated to be valued over USD 760 million by 2030. Rising awareness pertaining to…

"We are really enthusiastic about this technology," Tirrell said. "It directly targets the site of the inflammation and could have implications in a variety of vascular disorders." …

— Follows multiple global studies of savolitinib in papillary renal cell carcinoma patients including SAVOIR and CALYPSO — — In CALYPSO, savolitinib and IMFINZI® combination…

The drug was tolerated in two cohorts of patients, amounting to 88 individuals with brain metastases from kidney cancer. Some patients also received local treatment with surgery or…

A new study led by researchers from Nanjing University in China identified four circulating miRNAs, which are high in healthy people, and much lower in older people and diabetic patients. …